Detalles de la búsqueda
1.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol;
80(3): 431-442, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37972660
2.
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review.
Oncologist;
29(5): e580-e600, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309719
3.
Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
BMC Cancer;
24(1): 192, 2024 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38347461
4.
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.
Gastric Cancer;
27(3): 558-570, 2024 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38308771
5.
Targeting Angiogenesis Alone and in Combination with Immune Checkpoint Inhibitors in Advanced Gastroesophageal Malignancies.
Curr Gastroenterol Rep;
26(3): 57-67, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294661
6.
Who Should Receive Immunotherapy for Advanced Gastroesophageal Cancer?
Curr Treat Options Oncol;
25(4): 496-509, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38372852
7.
An initiative to implement a triage and referral system to make exercise and rehabilitation referrals standard of care in oncology.
Support Care Cancer;
32(4): 259, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561546
8.
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
Hepatology;
76(4): 1000-1012, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35313048
9.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Liver Int;
43(3): 695-707, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36577703
10.
A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicity.
J Oncol Pharm Pract;
29(8): 1951-1956, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883259
11.
Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment.
Int J Mol Sci;
24(22)2023 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38003695
12.
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.
Lancet Oncol;
23(11): 1430-1440, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36244398
13.
Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer.
Curr Issues Mol Biol;
44(11): 5756-5767, 2022 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36421674
14.
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
J Hepatol;
77(2): 397-409, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35367533
15.
Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology.
Oncologist;
27(9): 778-789, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35781739
16.
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma.
Liver Int;
42(11): 2538-2547, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35986902
17.
The prognostic and predictive impact of BRAF mutations in deficient mismatch repair/microsatellite instability-high colorectal cancer: systematic review/meta-analysis.
Future Oncol;
17(31): 4221-4231, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34323124
18.
Nivolumab in Esophageal Squamous-Cell Carcinoma.
N Engl J Med;
386(20): 1959, 2022 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35584167
19.
Preoperative Screening of Colorectal Cancers Is As Accurate As Postoperative Screening for Detection of Lynch Syndrome.
Clin Gastroenterol Hepatol;
18(10): 2372-2374.e1, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32428707
20.
Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review.
BMC Cancer;
20(1): 507, 2020 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32493233